EDGAR Filing Documents for 0001144204-13-013197

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

SEC Accession No. 0001144204-13-013197

Filing Date

2013-03-06

Accepted

2013-03-06 15:02:16

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 2	v337270_sc13ga2.htm	SC 13G/A	36348
	Complete submission text file	0001144204-13-013197.txt		37683

Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2

Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 5143323222

NYMOX PHARMACEUTICAL CORP (Subject) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50514 | Film No.: 13669284
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O NYMOX PHARMACEUTICAL CORPORATION 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT A8 H4M 2V2

Business Address

Averback Paul (Filed by) CIK: 0001569706 (see all company filings)

Type: SC 13G/A